Aurobindo Pharma Stock

Aurobindo Pharma Interest Coverage

The Interest Coverage Ratio of Aurobindo Pharma (AUROPHARMA.NS) as of Aug 15, 2026 is 47.55. In the previous year, Interest Coverage Ratio was 104.57 — a change of -54.53% (lower).

Interest Coverage

47.55

YoY

-54.53%

Last updated:

Interest Coverage Ratio of Aurobindo Pharma is 2026 47.55 . Interest Coverage Ratio of Aurobindo Pharma was 2025 104.57 . It decreases by -54.53% lower compared to the previous year.
Access this data via the Eulerpool API

Aurobindo Pharma Stock analysis

What does Aurobindo Pharma do? Aurobindo Pharma Ltd is a global pharmaceutical company based in India. It was founded in 1986 by P.V. Ramprasad Reddy, K. Nityananda Reddy, and Kambhampati Hari Babu. It has become one of the leading companies in the industry over the past 35 years. The company's business model is based on the production and distribution of generics, active pharmaceutical ingredients, and biosimilars. It operates in several divisions, covering a wide range of products. Aurobindo Pharma's main division is the manufacturing of generics, including both simple generics and complex products like biosimilars. The company also produces a variety of pharmaceutical ingredients used in industries such as pharmacy, cosmetics, and food. In addition, Aurobindo is involved in the production of biosimilars, which are biological drugs that have similar properties to existing biological products. These products have the potential to improve access to life-saving medications and generate significant cost savings. Aurobindo also manufactures products for the veterinary medicine industry, including antibiotics, antiparasitics, and vitamins. The company has also established a strong presence in the American market in recent years through acquisitions and offers a wide range of products. It has also expanded its presence in Europe, Asia, and Africa. In 2020, Aurobindo Pharma played a significant role in combating the COVID-19 pandemic by introducing several medications that can be used to treat the virus, such as hydroxychloroquine and azithromycin for mild to moderate cases. The company has earned a reputation as a leader in the generics and active pharmaceutical ingredient markets and aims to provide high-quality medications at affordable prices, making a positive contribution to global health improvement. Aurobindo Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aurobindo Pharma stock

Interest Coverage Ratio of Aurobindo Pharma is 47.55 in 2026.

Interest Coverage Ratio of Aurobindo Pharma changed from 104.57 to 47.55, representing a -54.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Aurobindo Pharma since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Aurobindo Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Aurobindo Pharma

All Key Metrics — Aurobindo Pharma